Diseases, Conditions, Syndromes

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk

While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives—and whether they posed increased ...

Diseases, Conditions, Syndromes

Research produces different results from key China COVID-19 study

Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...


SGLT2 inhibitors can slow progression of chronic kidney disease

Worldwide, 850 million people are affected by chronic kidney disease (CKD)—a worrying figure, and one that continues to rise. Treatment options for patients with CKD are multiple and often determined by the etiology of ...

page 1 from 6